ALBERT WINFIELD: Open Payments
NPI 1679588461 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 29 payments from 14 companies in 2025. Trend: 2023 $882 · 2024 $883 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| ABBVIE INC. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $52 |
| Exact Sciences Corporation | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Abbott Laboratories | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
Products named: REXULTI, CAPLYTA, MOUNJARO, Ozempic, XIFAXAN, VRAYLAR, FREESTYLE LIBRE 3, BREZTRI.
Industry payments across VA — which companies pay providers there.
